P1-310: FDG-PET Scan Significantly Superior to Spect Scan in The Diagnosis of Alzheimer's Disease in a Naturalistic Memory Clinic Setting

2016 ◽  
Vol 12 ◽  
pp. P541-P541
Author(s):  
Henry Zeimer ◽  
Sarah Moore ◽  
Danielle Polgar
2016 ◽  
Vol 208 (5) ◽  
pp. 491-496 ◽  
Author(s):  
Michael J. Firbank ◽  
Jim Lloyd ◽  
David Williams ◽  
Robert Barber ◽  
Sean J. Colloby ◽  
...  

BackgroundImaging biomarkers for Alzheimer's disease include medial temporal lobe atrophy (MTLA) depicted on computed tomography (CT) or magnetic resonance imaging (MRI) and patterns of reduced metabolism on fluorodeoxyglucose positron emission tomography (FDG-PET).AimsTo investigate whether MTLA on head CT predicts the diagnostic usefulness of an additional FDG-PET scan.MethodParticipants had a clinical diagnosis of Alzheimer's disease (n = 37) or dementia with Lewy bodies (DLB; n = 30) or were similarly aged controls (n = 30). We visually rated MTLA on coronally reconstructed CT scans and, separately and blind to CT ratings, abnormal appearances on FDG-PET scans.ResultsUsing a pre-defined cut-off of MTLA ⩾5 on the Scheltens (0–8) scale, 0/30 controls, 6/30 DLB and 23/30 Alzheimer's disease had marked MTLA. FDG-PET performed well for diagnosing Alzheimer's disease v. DLB in the low-MTLA group (sensitivity/specificity of 71%/79%), but in the high-MTLA group diagnostic performance of FDG-PET was not better than chance.ConclusionsIn the presence of a high degree of MTLA, the most likely diagnosis is Alzheimer's disease, and an FDG-PET scan will probably not provide significant diagnostic information. However, in cases without MTLA, if the diagnosis is unclear, an FDG-PET scan may provide additional clinically useful diagnostic information.


2020 ◽  
Vol 16 (S6) ◽  
Author(s):  
Willem S. Eikelboom ◽  
Michiel Coesmans ◽  
Ellen H. Singleton ◽  
Rik Ossenkoppele ◽  
John C. van Swieten ◽  
...  

2013 ◽  
Vol 9 ◽  
pp. P144-P145
Author(s):  
Flora Duits ◽  
Niels Prins ◽  
Evelien Lemstra ◽  
Yolande Pijnenburg ◽  
Femke Bouwman ◽  
...  

2017 ◽  
Vol 13 (7S_Part_7) ◽  
pp. P342-P342
Author(s):  
Niki S.M. Schoonenboom ◽  
Kees Kalisvaart ◽  
Mohammed Akarriou

PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e95755 ◽  
Author(s):  
Qianhua Zhao ◽  
Bin Zhou ◽  
Ding Ding ◽  
Satoshi Teramukai ◽  
Qihao Guo ◽  
...  

2016 ◽  
Vol 42 (3-4) ◽  
pp. 135-145 ◽  
Author(s):  
Jun Ho Lee ◽  
Min Soo Byun ◽  
Dahyun Yi ◽  
Young Min Choe ◽  
Hyo Jung Choi ◽  
...  

Aims: The aims of this study were to investigate the frequency of various depressive syndromes in elderly individuals with no cognitive impairment (NC), mild cognitive impairment (MCI), and Alzheimer's disease dementia (AD) in a memory clinic setting, and then to test whether severe and milder forms of depressive syndromes are differentially associated with the cognitive groups. Methods: For 216 NC, 478 MCI, and 316 AD subjects, we investigated the frequency of depressive syndromes, defined by three different categories: major and minor depressive disorder (MaDD and MiDD) according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, as well as depression according to the National Institute of Mental Health provisional diagnostic criteria for depression in Alzheimer's disease (NIMH-dAD). Results: The frequency of MaDD did not show any significant difference among NC, MCI, and AD. In contrast, the frequencies of MiDD and NIMH-dAD were higher than those of MaDD and showed significant group differences with a gradual increase from NC to AD. Conclusion: The findings suggest that the degenerative process of Alzheimer's disease contributes to the occurrence of mild depressive conditions, but not to severe depression.


2017 ◽  
Vol 46 (Suppl_3) ◽  
pp. iii1-iii12
Author(s):  
Robert Briggs ◽  
Cathy McHale ◽  
Deborah Fitzhenry ◽  
Tara Coughlan ◽  
Ronan Collins ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document